News
The House Judiciary Committee subpoenaed a former Pfizer executive who allegedly claimed senior members of the company ...
3don MSN
If your physician prescribes a new branded drug, though, you and your insurance company have few options. Patent-protected ...
Robert "Bob" Cooper of the L.A. firm Gibson Dunn defended some of the country’s largest and most recognizable companies from ...
Discover why options trading trends, robust R&D, and strong free cash flow position Pfizer Inc. for growth. Click for my ...
The House Judiciary Committee has subpoenaed a former Pfizer executive who is considered central to its investigation into an ...
A former Pfizer scientist was subpoenaed Monday by House Republicans over allegations that there was a conspiracy among ...
Despite recent declines, we believe Pfizer stock is a compelling buy right now, with its current price of around $23 likely reflecting existing concerns.
The House Judiciary Committee subpoenaed a former Pfizer Inc. executive, demanding he address allegations of deliberately ...
Pfizer offers a high 7.4% dividend yield and trades at low valuation multiples. Click here to read more about PFE stock and why it is a Buy.
In a recent regulatory development, the Subject Expert Committee (SEC) under the Dermatology and Allergy division of the ...
Pfizer (PFE) closed at $25.32 in the latest trading session, marking a +1.12% move from the prior day. The stock exceeded the S&P 500, which registered a gain of 0.48% for the day. Elsewhere, the Dow ...
(Reuters) -The U.S. House Judiciary Committee on Monday subpoenaed a former Pfizer executive after he declined to voluntarily ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results